HomeVLA • EPA
Valneva SE
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 52.94M | 26.36% |
Operating expense | 20.57M | -30.13% |
Net income | -36.99M | -15.02% |
Net profit margin | -69.86 | 8.98% |
Earnings per share | -0.54 | -14.57% |
EBITDA | -5.75M | 79.72% |
Effective tax rate | -14.34% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 168.27M | 33.46% |
Total assets | 500.03M | 8.69% |
Total liabilities | 318.78M | -3.93% |
Total equity | 181.25M | — |
Shares outstanding | 162.40M | — |
Price to book | 2.99 | — |
Return on assets | -10.05% | — |
Return on capital | -12.52% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -36.99M | -15.02% |
Cash from operations | 9.53M | 114.45% |
Cash from investing | 4.69M | 128.73% |
Cash from financing | -4.59M | -112.42% |
Net change in cash | 11.94M | 126.42% |
Free cash flow | 18.90M | 133.19% |
Previous close
€3.35
Day range
€3.26 - €3.37
Year range
€1.73 - €4.30
Market cap
523.87M EUR
Avg Volume
2.01M
P/E ratio
-
Dividend yield
-
Primary exchange
EPA
About
Valneva SE is a French biotech company headquartered in Saint-Herblain, France, developing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden, and Vienna, Austria; with other offices in France, Canada and the United States. Wikipedia
Founded
2013
Website
Employees
713
